Jones, Ronald N <br/><br/>
Ciprofloxacin as broad-spectrum empiric therapy--are fluoroquinolones still viable monotherapeutic agents compared with beta-lactams: data from the MYSTIC Program (US)?  [electronic resource] 

 -  Diagnostic microbiology and infectious disease  Mar 2002 
 - 213-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0732-8893 
<br/><br/><label>Standard No.: </label>10.1016/s0732-8893(01)00343-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anti-Bacterial Agents--pharmacology<br/>Ciprofloxacin--pharmacology<br/>Drug Resistance, Bacterial<br/>Drug Resistance, Multiple, Bacterial<br/>Gram-Negative Bacteria--drug effects<br/>Gram-Positive Bacteria--drug effects<br/>Humans<br/>Microbial Sensitivity Tests<br/>United States<br/>beta-Lactams